About
Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
28Traction
32Team
0Visibility
6Profile
55Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Umlaut.bio do?
Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.
How much funding has Umlaut.bio raised?
Umlaut.bio has raised a total of $3M in funding. The most recent round on record is Pre-Seed.
Where is Umlaut.bio headquartered?
Umlaut.bio is headquartered in Cambridge, Massachusetts, USA.
When was Umlaut.bio founded?
Umlaut.bio was founded in 2022.
What industry does Umlaut.bio operate in?
Umlaut.bio operates in Biotechnology, Cancer, Immunotherapy, Drug Discovery.